EMD Serono

EMD Serono

At EMD Serono—the healthcare business of Merck KGaA, Darmstadt, Germany, in the US and Canada—we strive every day to improve the futures of people living with cancer. Building on our 350-year global heritage as pharma pioneers to develop new therapies that can advance new standards of care, we are focusing our most promising science on Oncogenic Signaling, Antibody-Drug Conjugates, DNA Damage Response and Tumor Immunology to target cancer’s deepest vulnerabilities, pursuing differentiated molecules to strike cancer at its core.

Head and Neck Cancer, Lung Cancer, Clinical Trials, Immunotherapy, Pharmaceutical

Yes

Yes